ERYTECH provides financial update for Q1 2013 admERY June 3, 2013 Newsroom ERYTECH announced today its cash position and its revenues for first quarter 2013. You Might Also Like ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting December 3, 2020 ERYTECH Pharma to partner with Teva for long term distribution agreement in Israel May 17, 2011 ERYTECH to host a webcast on September 29, 2015 for its 2015 half-year results September 22, 2015
ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting December 3, 2020
